304 related articles for article (PubMed ID: 17331548)
1. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy.
Tomohiro T; Kumai T; Sato T; Takeba Y; Kobayashi S; Kimura K
Life Sci; 2007 Mar; 80(15):1364-72. PubMed ID: 17331548
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension.
Peixoto EB; Pessoa BS; Biswas SK; Lopes de Faria JB
Am J Nephrol; 2009; 29(4):309-18. PubMed ID: 18849601
[TBL] [Abstract][Full Text] [Related]
3. Hypertension increases pro-oxidant generation and decreases antioxidant defense in the kidney in early diabetes.
Biswas SK; Peixoto EB; Souza DS; de Faria JB
Am J Nephrol; 2008; 28(1):133-42. PubMed ID: 17951995
[TBL] [Abstract][Full Text] [Related]
4. Effects of aortic coarctation on aortic antioxidant enzymes and NADPH oxidase protein expression.
Sindhu RK; Roberts CK; Ehdaie A; Zhan CD; Vaziri ND
Life Sci; 2005 Jan; 76(8):945-53. PubMed ID: 15589970
[TBL] [Abstract][Full Text] [Related]
5. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
[TBL] [Abstract][Full Text] [Related]
6. Hypertension accelerates diabetic nephropathy in Wistar fatty rats, a model of type 2 diabetes mellitus, via mitogen-activated protein kinase cascades and transforming growth factor-beta1.
Imai G; Satoh T; Kumai T; Murao M; Tsuchida H; Shima Y; Ogimoto G; Fujino T; Kobayashi S; Kimura K
Hypertens Res; 2003 Apr; 26(4):339-47. PubMed ID: 12733703
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys.
Chandramohan G; Bai Y; Norris K; Rodriguez-Iturbe B; Vaziri ND
Am J Nephrol; 2008; 28(1):158-67. PubMed ID: 17951998
[TBL] [Abstract][Full Text] [Related]
8. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
[TBL] [Abstract][Full Text] [Related]
9. Isohumulones derived from hops ameliorate renal injury via an anti-oxidative effect in Dahl salt-sensitive rats.
Namikoshi T; Tomita N; Fujimoto S; Haruna Y; Ohzeki M; Komai N; Sasaki T; Yoshida A; Kashihara N
Hypertens Res; 2007 Feb; 30(2):175-84. PubMed ID: 17460388
[TBL] [Abstract][Full Text] [Related]
10. High salt intake enhances blood pressure increase during development of hypertension via oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats.
Koga Y; Hirooka Y; Araki S; Nozoe M; Kishi T; Sunagawa K
Hypertens Res; 2008 Nov; 31(11):2075-83. PubMed ID: 19098380
[TBL] [Abstract][Full Text] [Related]
11. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation.
Luo ZF; Feng B; Mu J; Qi W; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
Toxicol Appl Pharmacol; 2010 Jul; 246(1-2):49-57. PubMed ID: 20399799
[TBL] [Abstract][Full Text] [Related]
12. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
Abo-Salem OM; El-Edel RH; Harisa GE; El-Halawany N; Ghonaim MM
Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
[TBL] [Abstract][Full Text] [Related]
13. Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats.
Jeong KH; Lee TW; Ihm CG; Lee SH; Moon JY; Lim SJ
Am J Nephrol; 2009; 29(3):274-82. PubMed ID: 18812693
[TBL] [Abstract][Full Text] [Related]
14. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
15. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
[TBL] [Abstract][Full Text] [Related]
16. Lead-induced dysregulation of superoxide dismutases, catalase, glutathione peroxidase, and guanylate cyclase.
Farmand F; Ehdaie A; Roberts CK; Sindhu RK
Environ Res; 2005 May; 98(1):33-9. PubMed ID: 15721881
[TBL] [Abstract][Full Text] [Related]
17. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
[TBL] [Abstract][Full Text] [Related]
19. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
Prabhakar S; Starnes J; Shi S; Lonis B; Tran R
J Am Soc Nephrol; 2007 Nov; 18(11):2945-52. PubMed ID: 17928507
[TBL] [Abstract][Full Text] [Related]
20. Renal and metabolic effects of tempol in obese ZSF1 rats--distinct role for superoxide and hydrogen peroxide in diabetic renal injury.
Rafikova O; Salah EM; Tofovic SP
Metabolism; 2008 Oct; 57(10):1434-44. PubMed ID: 18803950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
